Literature DB >> 10051854

Aging process is accompanied by increase of transglutaminase C.

S C Park1, E J Yeo, J A Han, Y C Hwang, J Y Choi, J S Park, Y H Park, K O Kim, I G Kim, S C Seong, S J Kwak.   

Abstract

Crosslinking has been suggested as one of the mechanisms involved in the aging process. Among the various random or enzyme-mediated crosslinking reactions, transglutaminase (TGase)-catalyzed crosslinking activity has been proposed for its possible involvement in cell proliferation, differentiation, carcinogenesis, programmed death, and aging. Moreover, recent findings of TGase C as a putative signal transducer and cell cycle regulator has renewed interest in the study of TGase C in relation to aging phenomena. The ubiquitous presence of TGase C compared to the organ-specific localization of other types of TGases has attracted special attention as a cellular aging device. In the present investigation for in vitro studies, we have compared the pattern of TGase C in young and old human red blood cells, separated by density differentiation, and in early and late-passage or hydrogen peroxide-treated human primary fibroblasts. For in vivo study, we monitored the age-dependent changes of TGase C in the liver and brain tissues of 4, 12, 18, and 24-month-old Sprague-Dawley rats. We obtained evidence that both the activity and protein levels of TGase C were high in old RBC and late-passage or hydrogen peroxide-treated fibroblasts. Similar findings were seen in liver and brain tissue such as age-dependent increases in TGase activity and protein level in an organ-specific pattern. These data suggest that TGase C might play an active role in the cellular process with age.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051854     DOI: 10.1093/gerona/54.2.b78

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  5 in total

1.  Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.

Authors:  B D Chang; K Watanabe; E V Broude; J Fang; J C Poole; T V Kalinichenko; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 2.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

3.  Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease.

Authors:  Adrien W Schmid; Diego Chiappe; Vérène Pignat; Valerie Grimminger; Ivan Hang; Marc Moniatte; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

4.  Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes.

Authors:  Z Sarang; A Mádi; C Koy; S Varga; M O Glocker; D S Ucker; S Kuchay; A H Chishti; G Melino; L Fésüs; Z Szondy
Journal:  Cell Death Differ       Date:  2007-07-06       Impact factor: 15.828

5.  Toxicity of functional nano-micro zinc oxide tetrapods: impact of cell culture conditions, cellular age and material properties.

Authors:  Heike Papavlassopoulos; Yogendra K Mishra; Sören Kaps; Ingo Paulowicz; Ramzy Abdelaziz; Mady Elbahri; Edmund Maser; Rainer Adelung; Claudia Röhl
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.